MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-592-600$20.00
Mol Pharmacol 66:592-600, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moss, M. A.
Right arrow Articles by Rosenberry, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moss, M. A.
Right arrow Articles by Rosenberry, T. L.

Nordihydroguaiaretic Acid Does Not Disaggregate {beta}-Amyloid(1–40) Protofibrils but Does Inhibit Growth Arising from Direct Protofibril Association

Melissa A. Moss, Nicholas H. Varvel1, Michael R. Nichols, Dana Kim Reed, and Terrone L. Rosenberry

Department of Neurosciences, Mayo Clinic, Jacksonville, Florida

Nordihydroguaiaretic acid (NDGA) was observed by Ono et al. (J Neurochem 87:172–181, 2002) to decrease the fluorescence of thioflavin T associated with freshly extended amyloid {beta}-protein (A{beta}) fibrils. They concluded that NDGA could disaggregate A{beta} fibrils into aggregates that were larger than monomers or oligomers and did not bind thioflavin T. Such an effect could be of therapeutic importance in the treatment of Alzheimer's disease. In the current study, we confirmed that NDGA induces a decrease in the fluorescence of thioflavin T associated with A{beta}(1–40) fibrils and extended this observation to A{beta}(1–40) protofibrils. However, attempts to identify protofibril disaggregation products using dynamic light scattering, electron microscopy, and size exclusion chromatography failed to demonstrate any decrease in aggregate size or concentration or a parallel increase in A{beta} monomers or small oligomers when protofibrils were incubated with excess NDGA. We propose instead that the decreases in thioflavin T fluorescence resulted from either displacement or conformational alteration of thioflavin T upon the binding of NDGA to these aggregates. In fact, the same equilibrium fluorescence values were observed regardless of the order in which NDGA, thioflavin T, and A{beta} protofibrils were added to the incubation. Although NDGA failed to disaggregate A{beta} protofibrils, it did inhibit direct protofibril-protofibril association but did not alter protofibril elongation by monomer addition. These results suggest that NDGA might bind along the lateral surface of A{beta} protofibrils. In addition, the binding of NDGA to A{beta} protofibrils increased their nonspecific adherence to Superdex 75 resin and diminished their effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.


Received December 10, 2003; accepted June 1, 2004

Address correspondence to: Terrone L. Rosenberry, Department of Neurosciences, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224. E-mail address: rosenberry{at}mayo.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
K. Arasaki, K. Tani, T. Yoshimori, D. J. Stephens, and M. Tagaya
Nordihydroguaiaretic Acid Affects Multiple Dynein-Dynactin Functions in Interphase and Mitotic Cells
Mol. Pharmacol., February 1, 2007; 71(2): 454 - 460.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Zhang, J. Sawashita, X. Fu, T. Korenaga, J. Yan, M. Mori, and K. Higuchi
Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods
FASEB J, May 1, 2006; 20(7): 1012 - 1014.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics